Position in ALEC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,529,365
+$594,039 QoQ
Shares Held
711,334
+18.6% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,607,351,941 across 214 Biotechnology names. ALEC ranks #109 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in ALEC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,529,365 | 711,334 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $935,326 | 599,569 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,296,736 | 438,087 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $569,264 | 406,618 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $605,886 | 492,592 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,063,948 | 562,936 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $969,283 | 208,001 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $837,678 | 184,511 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,145,063 | 190,210 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $524,022 | 65,667 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $413,404 | 63,797 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $145,448 | 24,201 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $466,348 | 75,339 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,658,335 | 179,668 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,206,024 | 656,028 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,581,714 | 352,531 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,369,604 | 166,288 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,870,394 | 90,576 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $788,179 | 34,539 | Shares | Defined | 2021-11-15 | |
| 2020-09-30 | $167,833 | 15,931 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||